Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Metformin

  • You have access
    Relationship Between Metabolic Reprogramming and Mitochondrial Activity in Cancer Cells. Understanding The Anticancer Effect of Metformin and Its Clinical Implications
    MASSIMILIANO CAZZANIGA and BERNARDO BONANNI
    Anticancer Research November 2015, 35 (11) 5789-5796;
  • You have access
    Survival Advantage Associated with Metformin Usage in Hepatocellular Carcinoma Patients Receiving Radiotherapy: A Propensity Score Matching Analysis
    WON IL JANG, MI-SOOK KIM, JUNG SUB LIM, HYUNG JUN YOO, YOUNG SEOK SEO, CHUL JU HAN, SU CHEOL PARK, CHUL SEUNG KAY, MYUNGSOO KIM, HONG SEOK JANG, DONG SOO LEE, AH RAM CHANG and HAE JIN PARK
    Anticancer Research September 2015, 35 (9) 5047-5054;
  • You have access
    Resistance to Gemcitabine in the Pancreatic Cancer Cell Line KLM1-R Reversed by Metformin Action
    BYRON BARON, YUFENG WANG, SHIN-ICHIRO MAEHARA, YOSHIHIKO MAEHARA, YASUHIRO KURAMITSU and KAZUYUKI NAKAMURA
    Anticancer Research April 2015, 35 (4) 1941-1949;
  • You have access
    Metformin Inhibits Tumor Cell Migration via Down-regulation of MMP9 in Tamoxifen-resistant Breast Cancer Cells
    SOON YOUNG JANG, AEREE KIM, JIN KYOUNG KIM, CHUNGYEL KIM, YOUL-HEE CHO, JONG-HO KIM, CHUL HWAN KIM and JI-YUN LEE
    Anticancer Research August 2014, 34 (8) 4127-4134;
  • You have access
    Metformin Suppresses Sonic Hedgehog Expression in Pancreatic Cancer Cells
    MASAFUMI NAKAMURA, AYAKO OGO, MASAHIRO YAMURA, YOSHIYUKI YAMAGUCHI and HIROSHI NAKASHIMA
    Anticancer Research April 2014, 34 (4) 1765-1769;
  • You have access
    Regulation of the Proliferation of Colon Cancer Cells by Compounds that Affect Glycolysis, Including 3-Bromopyruvate, 2-Deoxyglucose and Biguanides
    MICHAEL A. LEA, MEHREEN S. QURESHI, MICHAEL BUXHOEVEDEN, NICOLETTE GENGEL, JESSICA KLEINSCHMIT and CHARLES desBORDES
    Anticancer Research February 2013, 33 (2) 401-407;
  • You have access
    Metformin and the mTOR Inhibitor Everolimus (RAD001) Sensitize Breast Cancer Cells to the Cytotoxic Effect of Chemotherapeutic Drugs In Vitro
    HONGYU LIU, CHRISTIAN SCHOLZ, CHUANBING ZANG, JAN H. SCHEFE, PIET HABBEL, ANNE-CONSTANZE REGIERER, CARSTEN-OLIVER SCHULZ, KURT POSSINGER and JAN EUCKER
    Anticancer Research May 2012, 32 (5) 1627-1637;

Pages

  • Previous
  • 1
  • 2
  • 3
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire